Albumin-induced coagulopathy is less severe and more effectively reversed with fibrinogen concentrate than is synthetic colloid-induced coagulopathy.
about
Assessing the Methodology for Calculating Platelet Contribution to Clot Strength (Platelet Component) in Thromboelastometry and ThrombelastographyCorrection of hypothermic and dilutional coagulopathy with concentrates of fibrinogen and factor XIII: an in vitro study with ROTEMAssays of different aspects of haemostasis - what do they measure?Effects of different colloid infusions on ROTEM and Multiplate during elective brain tumour neurosurgery.Cross-Sectional Guidelines for Therapy with Blood Components and Plasma Derivatives: Chapter 5 Human Albumin - RevisedRotational thromboelastometry and multiple electrode platelet aggregometry in four patients with abnormal routine coagulation studies before removal of epidural catheters after major surgery: a case series and research study.Albumin-Beyond Fluid Replacement in Cardiopulmonary Bypass Surgery: Why, How, and When?Anticoagulant action of low, physiologic, and high albumin levels in whole blood.Fibrinogen and FXIII dose response effects on albumin-induced coagulopathy.Effects of Dextran-70 and Albumin on Coagulation in Experimental Hemorrhage in the Guinea Pig.Intraoperative Hydroxyethyl Starch and its Effects on Different Fibrinogen Measurements.ROTEM monitoring of activated and non-activated prothrombin complex concentrate correction of dilutional coagulopathy.Comparison of dextran and albumin on blood coagulation in patients undergoing major gynaecological surgery
P2860
Q26785877-815AE5C4-A407-486A-B73F-B605032DBAD9Q34746641-F5049F99-292C-4789-8894-E62D7DEE859CQ35086946-1103C2D8-F41A-401D-91E5-B0C87545C1CDQ36107989-BF455273-A43F-4EBE-AA7B-DE9C171F5B2AQ37045780-22622C54-A0EB-4FE4-B7F0-35405166F306Q37480049-20E18ED0-8038-42D5-96FA-0A354DDA653AQ38214993-B5E42CC5-27A7-4135-891F-8B649AD18220Q41363216-FE765D2D-A941-41E7-A3F3-9576034A29FAQ43416132-35178D35-5B7B-4554-9CE1-3B2850F73613Q47239938-CEB24A1F-BE2B-467C-9F19-4F15EA30B487Q47588696-9EB70A3B-9A0D-4135-8772-E10D2DACD377Q53242381-58DDE723-DA32-412B-B23A-6ACA6A1758BFQ57160255-AD6AA5C8-E78A-498F-9C73-F1A48AEB67F1
P2860
Albumin-induced coagulopathy is less severe and more effectively reversed with fibrinogen concentrate than is synthetic colloid-induced coagulopathy.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年学术文章
@wuu
2013年学术文章
@zh
2013年学术文章
@zh-cn
2013年学术文章
@zh-hans
2013年学术文章
@zh-my
2013年学术文章
@zh-sg
2013年學術文章
@yue
2013年學術文章
@zh-hant
name
Albumin-induced coagulopathy i ...... colloid-induced coagulopathy.
@en
Albumin-induced coagulopathy i ...... colloid-induced coagulopathy.
@nl
type
label
Albumin-induced coagulopathy i ...... colloid-induced coagulopathy.
@en
Albumin-induced coagulopathy i ...... colloid-induced coagulopathy.
@nl
prefLabel
Albumin-induced coagulopathy i ...... colloid-induced coagulopathy.
@en
Albumin-induced coagulopathy i ...... colloid-induced coagulopathy.
@nl
P2093
P2860
P1476
Albumin-induced coagulopathy i ...... colloid-induced coagulopathy.
@en
P2093
Dag Winstedt
Jennifer Hanna
Ulf Schött
P2860
P304
P356
10.3109/00365513.2012.762114
P577
2013-02-01T00:00:00Z